Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
3 hedge funds and large institutions have $46K invested in Nemaura Medical, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
254% more capital invested
Capital invested by funds: $13K → $46K (+$33K)
200% more funds holding
Funds holding: 1 → 3 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$42.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$662 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $36K | +$42.4K | +4,995 | New |
|
|
SC
2
Scotia Capital
Toronto,
Ontario, Canada
| $9K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | +$662 | +78 | New |
|
NMRD Hedge Fund Activity: Q3 2019 in Review
3 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q3 2019, worth a combined $46K — up 254% from $13K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NMRD positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $42.4K.
- 3 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q3 2019, up from 1 in Q2 2019.
- Funds reported $46K of Nemaura Medical, Inc. Common Stock stock for Q3 2019, up 254% quarter-over-quarter.
- 2 funds opened new Nemaura Medical, Inc. Common Stock positions in Q3 2019 and 0 closed out, a net change of +2 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q3 2019 was Citadel Advisors, an estimated $42.4K added.
Based on aggregated 13F filings for Q3 2019.